Genetika+ is in the process of creating a personalized medical testing solution aimed at improving the treatment of depression by assisting doctors in identifying the most suitable drug therapy for their patients. The Genetika+ test utilizes advanced technology to forecast the most effective drug treatment for each individual, leading to faster therapy, reduced side effects, and lower medication dosage. Their platform is specifically designed to employ AI-based scoring algorithms across Genetika+'s expanding repository of patients' neurons in order to determine the most appropriate treatment for each patient. This supports the efforts of researchers and biopharmaceutical companies in developing new treatments, enhancing the design of clinical trials, evaluating risks, and promoting precision medicine.